HCA Midwest Division - Sarah Cannon Cancer Institute — Kansas City, Missouri

HCA Midwest Division - Sarah Cannon Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

HCA Midwest Division - Sarah Cannon Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Platinum Resistant Ovarian Cancer.

Sponsors: Mateon Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Missouri · View every site in Kansas City

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Division - Sarah Cannon Cancer Institute?

HCA Midwest Division - Sarah Cannon Cancer Institute has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Division - Sarah Cannon Cancer Institute conducted?

HCA Midwest Division - Sarah Cannon Cancer Institute has 1 clinical trials on record. Their work covers Platinum Resistant Ovarian Cancer.

Is HCA Midwest Division - Sarah Cannon Cancer Institute accredited by Crixeo Clinical Trials?

HCA Midwest Division - Sarah Cannon Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Division - Sarah Cannon Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.